Literature DB >> 28534991

Long non-coding RNA XLOC_006390 promotes cervical cancer proliferation and metastasis through the regulation of SET domain containing 8.

Xiaotian Luan1, Yankui Wang1.   

Abstract

The long non-coding RNA (lncRNA) XLOC_006390 is increased in various human cancer tissues and it plays important roles in cell growth and migration. However, the role of lncRNA XLOC_006390 in the progression and metastasis of cervical cancer has not been evaluated and remains unclear. In the present study, we hypothesized that lncRNA XLOC_006390 is also increased in cervical cancer, and upregulation of lncRNA XLOC_006390 contributes to cervical cancer metastasis. The expression of lncRNA XLOC_006390 in cervical cancer tissues and cell lines was analyzed using quantitative reverse-transcription-polymerase chain reaction (qRT-PCR). RNA interference approach and an overexpression system were used to investigate the cellular functions of XLOC_006390 and SET domain containing 8 (SET8). Cell Counting Kit-8 (CCK-8) assay was performed to detect cell proliferation. Cell migration and invasion abilities were evaluated by Transwell assays. Western blotting and immunofluorescence were performed to detect SET8 protein expression. The results revealed that XLOC_006390 was increased in cervical cancer tissues. Patients with high XLOC_006390 expression were associated with FIGO stages III and IV (P=0.0170), lymphatic metastasis (P=0.0078) and distant metastasis (P=0.0025). Furthermore, SET8 was also increased in cervical cancer tissues and its expression was positively associated with XLOC_006390, and XLOC_006390 regulated SET8 expression. In addition, knockdown or overexpression of XLOC_006390 and SET8 expression suppressed or promoted cervical cancer cell proliferation, migration and invasion in vitro, respectively. In conclusion, our data suggest that lncRNA XLOC_006390 promotes cervical cancer cell growth and metastasis through the regulation of SET8, at least partly, which indicate the critical roles of XLOC_006390 and SET8 in cervical cancer progression and metastasis.

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 28534991     DOI: 10.3892/or.2017.5663

Source DB:  PubMed          Journal:  Oncol Rep        ISSN: 1021-335X            Impact factor:   3.906


  5 in total

1.  LncRNA SNHG6 enhances the radioresistance and promotes the growth of cervical cancer cells by sponging miR-485-3p.

Authors:  Jin Liu; Xiaojiao Liu; Rong Li
Journal:  Cancer Cell Int       Date:  2020-08-31       Impact factor: 5.722

Review 2.  Epigenetic modification regulates tumor progression and metastasis through EMT (Review).

Authors:  Tingshan Tan; Pengfei Shi; Muhammad Nadeem Abbas; Yi Wang; Jie Xu; Yu Chen; Hongjuan Cui
Journal:  Int J Oncol       Date:  2022-04-21       Impact factor: 5.884

3.  Long Noncoding XLOC_006390 Regulates the Proliferation and Metastasis of Human Colorectal Cancer via miR-296/ONECUT2 Axis.

Authors:  Tianyi Ma; Tianyu Qiao; Rui Huang; Meng Wang; Hanqing Hu; Ziming Yuan; Yihao Zhu; Hongyu Wu; Xiaoming Zou
Journal:  J Oncol       Date:  2022-07-15       Impact factor: 4.501

4.  LncRNA XLOC_006390 facilitates cervical cancer tumorigenesis and metastasis as a ceRNA against miR-331-3p and miR-338-3p.

Authors:  Xiaotian Luan; Yankui Wang
Journal:  J Gynecol Oncol       Date:  2018-11       Impact factor: 4.401

5.  SE translation mRNA overexpression: a potential prognostic predictor in breast cancer.

Authors:  Qian Du; Ruifang Hao; Leichao Liu; Yang Liu; Siying Chen; Haisheng You; Ying Zhang; Yalin Dong
Journal:  Transl Cancer Res       Date:  2019-09       Impact factor: 1.241

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.